Insights

Strategic partnerships Potential sales opportunity through co marketing and distribution collaborations with pet product retailers and health brands, leveraging MBT's BiomeBliss prebiotic to reach pet wellness markets and cross sell to human GI microbiome enthusiasts via bundled offerings.

Pet wellness expansion Target veterinary and pet care channels given past collaboration with PetGiftz and the emphasis on dog dietary supplements, presenting a channel to scale pet probiotic and prebiotic products across clinics, online pet stores, and subscription services.

Early stage potential MBT shows a history of product launches and a Series B financing milestone, suggesting readiness for partnerships that accelerate R&D, regulatory navigation, or co development of next generation microbiome modulators and gut health solutions.

Global yet lean Small team size indicates agility but limited internal capabilities; offer enterprise level distribution, regulatory consulting, manufacturing scale up, and go to market services to augment their growth without heavy internal investments.

Digital engagement Existing tech stack and analytics presence imply opportunities to offer digital marketing, website optimization, e commerce integration, and data driven customer acquisition services to improve visibility and online sales for BiomeBliss and related products.

Similar companies to Microbiome Therapeutics

Microbiome Therapeutics Tech Stack

Microbiome Therapeutics uses 8 technology products and services including WordPress, Google Fonts API, Twemoji, and more. Explore Microbiome Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • GoDaddy
    Web Hosting

Microbiome Therapeutics's Email Address Formats

Microbiome Therapeutics uses at least 1 format(s):
Microbiome Therapeutics Email FormatsExamplePercentage

Frequently Asked Questions

What is Microbiome Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Microbiome Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Microbiome Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Microbiome Therapeutics's official website is mbiome.com and has social profiles on LinkedIn.

What is Microbiome Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Microbiome Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Microbiome Therapeutics have currently?

Minus sign iconPlus sign icon
As of July 2026, Microbiome Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Consulting CFO: G. K.Sales Representative: G. P.. Explore Microbiome Therapeutics's employee directory with LeadIQ.

What industry does Microbiome Therapeutics belong to?

Minus sign iconPlus sign icon
Microbiome Therapeutics operates in the Biotechnology Research industry.

What technology does Microbiome Therapeutics use?

Minus sign iconPlus sign icon
Microbiome Therapeutics's tech stack includes WordPressGoogle Fonts APITwemojijQueryjQuery UIPHPGoogle AnalyticsGoDaddy.
Microbiome Therapeutics logo

Microbiome Therapeutics

Biotechnology ResearchColorado, United States11-50 Employees

Microbiome Therapeutics is a biotechnology research company focused on applying knowledge of the gastrointestinal microbiome to health and wellness. Based in Broomfield, Colorado, at 11001 West 120th Avenue, the company has between 11 and 50 employees. The firm has developed products such as BiomeBliss, a patented prebiotic dietary supplement intended to support a healthy GI microbiome, which was launched in April 2018; it also introduced a microbiome modulator in November 2017. The company pursues business partnerships, including a 2021 cooperative marketing arrangement with PetGiftz to promote a dog-focused BiomeBliss product. The organization maintains a website at mbiome.com and has financing activity around 2017.

Section iconCompany Overview

Phone number
Website
mbiome.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M

    Microbiome Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Microbiome Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.